RyanJMattisonMD
Hematology • Madison, WIHematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Associate Professor at the University of Wisconsin
Dr. Mattison is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-265-1700Fax+1 608-266-6020
Summary
- Dr. Ryan Mattison is a hematologist in Madison, WI and is affiliated with University Hospital. He received his medical degree from University of Iowa Roy J. and Lucille A. Carver College of Medicine and has been in practice 15 years. He specializes in hematologic oncology and myeloproliferative disorder hematology-oncology and is experienced in bone marrow failure syndromes, myelodysplasia, hematopoietic stem cell transplantation, hodgkin's lymphoma, and lymphoma.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2006 - 2009
University of North Carolina HospitalsResidency, Internal Medicine, 2002 - 2006
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2002
Certifications & Licensure
WI State Medical License 2009 - 2025
IL State Medical License 2006 - 2017
NC State Medical License 2002 - 2007- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- FLT-PET Imaging for MDS Start of enrollment: 2012 Jul 01
- Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2013 Feb 12
- Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Feb 04
Publications & Presentations
PubMed
- 13 citationsComparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia.Muhammad Umair Mushtaq, Alexandra M. Harrington, Sibgha Gull Chaudhary, Laura C. Michaelis, Karen Carlson
Leukemia & Lymphoma. 2021-01-02 - 129 citationsVenetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.Vinod Pullarkat, Norman J. Lacayo, Elias Jabbour, Jeffrey E. Rubnitz, Ashish Bajel
Cancer Discovery. 2021-02-16 - 97 citationsMLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genomeQianfei Wang, George Wu, Shuangli Mi, Fuhong He, Jun Wu
Blood. 2011-06-23
Abstracts/Posters
- Real-World Application of Molecular Genetic Sequencing in the Management of Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes: The Wisconsin ExperienceRyan J. Mattison, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with BlinatumomabRyan J. Mattison, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Inotuzumab OzogamicinRyan J. Mattison, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Authored Content
- Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-lineage Acute Lymphoblastic Leukemia in Measurable Residual Disease Negative Remission: Results from the ECOG-ACRIN E1910 Randomized Phase III National Cooperative Clinical Trials Network TrialDecember 2022
Press Mentions
Charlie Murphy Died of Leukemia, a Blood Cancer That Affects the Immune SystemApril 13th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
